Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2005, p. 4911-4913, Vol. 43, No. 9
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.9.4911-4913.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |
Departments of Internal Medicine,1 Laboratory Medicine,2 Pathology, National Taiwan University Hospital,3 School of Medical Technology, National Taiwan University College of Medicine, Taipei, Taiwan4
Received 6 April 2005/ Returned for modification 22 April 2005/ Accepted 17 May 2005
|
|
|---|
|
|
|---|
In early December 2002, a progressive cough with yellowish sputum developed 3 weeks after he returned from a 1-month visit to China. He did not have fever, dyspnea, or sore throat. A chest radiograph taken after arrival at the emergency department on 3 January 2003 showed bilateral pneumonia with multiple cavities (Fig. 1A). Gram- and acid-fast-stained smears of sputum collected on 5 January 2003 were negative for significant pathogens. Recurrence of tuberculosis was suspected, and empirical treatment with antituberculosis agents (isoniazid, rifampin, ethambutol, and pyrazinamide) was administered. However, aggravated dyspnea and intermittent fever (up to 38.2°C) occurred despite therapy with these agents. His white blood cell count was 10.50 x 109/liter (neutrophils, 92.0%; lymphocytes, 2.3%). Intravenous ampicillin/sulbactum (1.5 g every 6 h) was added. Chest computed tomography showed multiple ill-defined consolidations and cavitations in all of the lobes of both lungs and absence of mediastinal lymphadenopathy. Transthoracic lung aspiration and a biopsy were performed on 7 February. Pathology study showed many budding yeasts within and outside the histiocytes (Fig. 1B). Recurrent histoplasmosis with severe pneumonia was suspected. No abnormality was found other than the previously excised laryngeal lesion. A Gram-stained smear of the sputum specimen collected on 5 January 2003 was rechecked, and many unstained yeasts with hyphae were found (Fig. 1C). Cultures of sputum specimens and the biopsied lung tissue both grew H. capsulatum 10 days after inoculation.
![]() View larger version (51K): [in a new window] |
FIG. 1. (A) A chest radiograph taken at presentation reveals pneumonia and multiple cavitary lesions over both lungs. (B) Liu's staining of the biopsied lung tissue reveals many budding yeasts within and outside the histiocytes (x1,000 magnification). (C) Gram-stained smear of sputum demonstrates many unstained yeasts without hyphae (x1,000 magnification).
|
The nucleotide sequences of the internal transcribed spacer (ITS) regions of rRNA genes (including ITS1, the 5.8S rRNA gene, and ITS2) of the H. capsulatum isolate recovered from biopsied lung tissue and the extracted fungal DNA from the laryngeal tumor were examined using two sets of primers according to a previous description (5, 6). The sequences obtained were analyzed using GCG software (Wisconsin package; version 10.1 for Unix) and the BLASTN program (National Center for Biotechnology Information [NCBI] Internet homepage). Both sequences showed 99% identity to H. capsulatum (accession number AB055244). The similarity between the two sequences was analyzed further using the BL2SEQ program (NCBI Internet homepage). Results showed 100% identity in the 515-bp fragment produced by PCR. Comparison of the ITS sequences of a set of H. capsulatum isolates obtained from the GenBank (NCBI Internet homepage) and those found in this study failed to disclose 100% identity (accession numbers AB055248 [97.52% identity], AB055247 [97.11%], AB055246 [98.17%], AB055242 [98.58%], AB055239 [98.78%], AB055237 [98.37%], AB055230 [96.53%], AB055228 [96.52%], AB071770 [96.52%], AB071835 [98.1%], AB061781 [98.17%], and AB055243 [98.3%]).
Discussion. Previous study demonstrated that ITS typing by reading nucleotide sequences, not by analysis of DNA banding patterns using restriction fragment length polymorphism of mitochondrial DNA or randomly amplified polymorphic DNA, could provide a sufficient tool for classifying H. capsulatum isolates (6). Although the isolate from the laryngeal lesion was not preserved for this study, the genetic relationship between the ITS regions of the isolate and of the laryngeal lesion has clearly established the recurrent nature of infection.
Recurrent histoplasmosis is rare even in AIDS patients (4, 12). Recurrence or reactivation of histoplasmosis has been reported for patients with antifungal therapy of inadequate duration and dosage (1, 2, 9, 10, 13). Patients treated with infliximab and corticosteroid may be at increased risk of reactivation of latent histoplasmosis (3, 9-11, 13). This patient had undergone long-term corticosteroid treatment, which might have contributed to the recurrence of histoplasmosis. Misinterpretation of the stained smear of the initial sputum specimen led to a delay in diagnosis. A large burden of yeasts in the lung and delayed administration of antifungal agents also seem likely to have contributed to the poor outcome for the patient (8).
Histoplasmosis is a rare disease in Taiwan, and few microbiologically documented cases have been previously reported (7). A seroepidemiological study using a histoplasmin skin test in Taiwan in 1953 suggested that histoplasmosis did not exist in Taiwan at that time (7). This is the first reported case of recurrent and fatal histoplasmosis presenting with acute pneumonia in a non-AIDS patient from Taiwan. A previous study showed that histoplasmosis was endemic in China, particularly in the southeast region (14). The seropositivity rate was 25.5% overall but was significantly higher (31.7%) in patients with tuberculosis. Review of our patient's travel history and clinical course suggested that the first H. capsulatum strain was acquired either in China or in one of the other Asian countries that he had visited at least 9 years prior to this admission. The latency between initial presentation and clinical recurrence of histoplasmosis has been reported to be up to 13 years (3).
Histoplasmosis is commonly diagnosed in areas of endemicity but frequently overlooked in areas of nonendemicity due to a low index of suspicion among physicians (7, 8). Because of increasing intercontinental travel and also the possibility of recurrence after several years of latency, physicians in areas of nonendemicity should be alert to the possibility of the presence of H. capsulatum, which can cause localized infection, acute and life-threatening pneumonia, and disseminated diseases. Immunocompromised patients with a recent history of travel to or exposure to areas of endemicity are at the highest risk of such infection. Prompt microbiological investigation should be undertaken to make an accurate diagnosis and provide early and appropriate antifungal treatment.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»